Lindsey Carr, Editor

The American Association of Gynecologic Laparoscopists (AAGL) begins their 51st Global Congress on Minimally Invasive Gynecologic Surgery today in Aurora, Colorado, which will continue until Sunday, December 4. Follow along for coverage.

Revisit this month's issue of Contemporary OB/GYN®.

Testing the ratio between 2 placental proteins may be an early predictor of women at risk of developing preeclampsia with severe features.

A look at what's coming to Contemporary OB/GYN this week.

Take a look at the week's top stories.

In this bonus episode, Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.

This month's top news stories.

In this episode of Pap Talk, Alison Cowan, MD, discusses her predictions for women's health trends in 2023.

Results from a randomized controlled trial study suggest dextromethorphan may even worsen patient pain experience.

Bacterial vaginosis during pregnancy may lead to increased risks for preterm birth, preterm delivery, and spontaneous abortion, according to new research in the Archives of Gynecology and Obstetrics.

A look ahead at this week in women's health from Contemporary OB/GYN:

Take a look back at this week's top news stories.

Daré Bioscience announced yesterday that it has received a grant from the Bill & Melinda Gates Foundation of $584,986 to support its efforts related to the development of a vaginal thermosetting gel formulation for the delivery of live biotherapeutics that can be reconstituted at the point of care.

The Food and Drug Administration (FDA) has approved Medicine360’s supplemental new drug application to extend the use of its levongestrel-releasing intrauterine system 52mg (LILETTA) to prevent pregnancy for up to 8 years.

A new NIH study found women who used chemical hair straightening products to be at a higher risk for uterine cancer than women who didn’t use these products.

What's coming to Contemporary OB/GYN this week?

A look back at the week's headlines.

Houston, Texas, was buzzing with the latest updates in women’s health at the 25th Annual Nurse Practitioners in Women’s Health Premier Women’s Healthcare Conference held from September 29 to October 2, 2022.

Take a look inside this month's issue.

November is Diabetes Awareness Month.

What's coming to Contemporary OBGYN this week?

Pfizer announced that its bivalent respiratory syncytial virus vaccine—when given to women during pregnancy—has shown effective in protecting infants from reducing severe symptoms during their first 6 months of birth.

This month's top news stories.

What's coming to Contemporary OB/GYN this week?

Take a look at this week's top headlines.

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.

What's coming to Contemporary OB/GYN® this week?

Women in the US are more likely to be murdered during pregnancy or soon after childbirth than to die from the country’s top 3 leading causes of maternal death—high blood pressure disorders, hemorrhage, or sepsis—according to research in The BMJ.

A look back at the week's news.

Katie Huffling, DNP, RN, CNM, FAAN, sits down to discuss highlights of her presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.